This webinar will outline the various PCORI reauthorization bills and amendments that have been discussed by House and Senate committees to date. Our panel of experts will also explore some of the critical questions facing congressional staff and discuss potential next steps in the legislative process.
During this briefing, expert panelists discussed considerations for policy options to protect consumers from surprise medical bills.
This congressional briefing will explore the status of patient experience measurement.
There is no excerpt because this is a protected post.
This briefing highlighted policy options to promote health care coverage and affordability through the individual health insurance market. Our panel discussed trends in commercial health insurance enrollment and affordability.
This briefing identified policies to prevent pregnancy-related deaths and address the forces resulting in the disproportionate maternal health outcomes. Panelists discussed policy options that support interventions among providers and public health entities to address the clinical and social drivers of maternal mortality and severe maternal morbidity.
There is no excerpt because this is a protected post.
During this webinar, panelists explored the relationship between patents, prices, and patient access.
This briefing informed attendees about the purpose and perspectives surrounding comparative effectiveness research, including how researchers conduct CER studies and how various stakeholders may utilize the results. Panelists explored the current CER policy landscape.
There is no excerpt because this is a protected post.
During this briefing, panelists explained the mechanisms of biologic drugs, explore the impact of current regulations on the uptake of biosimilars, and discuss considerations for the biosimilars market in the United States.
The on-the-record, reporter-only briefing will begin with remarks from Rep. DeGette, followed by a moderated question and answer session.
During this summit, panelists explored how we can reframe the conversation around aging in America and discussed opportunities to improve health outcomes for older adults. Speakers discussed innovative payment models and approaches to integrating non-medical needs into those models as well as upcoming policy and regulatory priorities.
The panelists discussed the recent ruling made by the United States District Court for the Northern District of Texas on the Affordable Care Act.
The Program Assistant will be a critical part of the Alliance policy team. Our ability to accomplish our mission to foster health policy knowledge, understanding, and dialogue depends upon the consistent production of high-quality and unbiased programming for our core audience, including members of Congress, congressional and executive branch staff, media, and health policy stakeholders. The Program Assistant will ensure our logistical planning processes run smoothly and will convey a polished, professional image to our speakers and event attendees.
The Alliance for Health Policy seeks a highly motivated and energetic individual for the position of events and outreach assistant who is looking to gain insight into the internal operations and business development of a not-for-profit organization. This position has a key role in fundraising and development as well as events coordination and planning for the organization. The events and outreach assistant will support the management of strategic relationships for the organization and provide administrative support for the President and CEO.
This briefing is the last event in our 2018 Signature Series and we will explore the unique health and social needs of older adults and how to develop age-friendly communities that give aging Americans convenient access to all of the services they need.
The audience will come away with a better understanding of the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.
This webinar examined the role of health care in the upcoming elections and the potential health policy implications for Congress, the administration, and state governments.